Keith Tapper
Stock Analyst at BMO Capital
(0)
# 4790
Out of 5,270 analysts
5
Total ratings
40.00%
Success rate
-24.34%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Neurogene | Maintains: Outperform | 60 45 | 16.34 | 175.4% | 3 | Nov 20, 2024 | |
Taysha Gene Therapie... | Initiates Coverage On: Outperform | 5 | 1.6 | 212.5% | 1 | Jun 27, 2024 | |
ACADIA Pharmaceutica... | Initiates Coverage On: Outperform | 31 | 18.14 | 70.89% | 1 | Jun 27, 2024 |